By Iain Gilbert
Date: Wednesday 29 Jan 2025
LONDON (ShareCast) - (Sharecast News) - Medical device business RUA Life Sciences said on Wednesday that it has inked a new supply agreement with an initial value of more than £500,000.
RUA said it has now entered a multi-year supply contract with a global customer that covers two product lines, unit volumes and unit pricing.
The AIM-listed firm stated revenue expected during the current calendar year was anticipated to grow over time with a potential value of £3.3m over a five-year period.
RUA also highlighted that the new contract represented a six-fold increase on the level of business undertaken for the customer prior to commencing work on the project.
Chief executive Bill Brown said: "The RUA Quality, R&D and Production teams worked closely with our global customer to exceed their expectations during the project phase which resulted with this long-term partnership."
As of 1020 GMT, RUA shares were up 6.12 % at 13.0p.
Reporting by Iain Gilbert at Sharecast.com
Email this article to a friend
or share it with one of these popular networks:
Currency | UK Pounds |
Share Price | 11.50p |
Change Today | 0.000p |
% Change | 0.00 % |
52 Week High | 14.75 |
52 Week Low | 10.25 |
Volume | 0 |
Shares Issued | 62.06m |
Market Cap | £7.14m |
Beta | 0.02 |
RiskGrade | 290 |
Value |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Price Trend |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
Income | ![]() |
---|
Growth |
![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() ![]() |
---|
No dividends found |
Chair | William D Brown |
CFO | Lachlan Smith |
You are here: research